2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies

doi:10.1016/j.atherosclerosis.2019.08.014

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Authors/Task Force Members
, ESC Committee for Practice Guidelines (CPG)
, ESC National Cardiac Societies

Cardiology Department
University of Geneva
University of Oxford
Department of Pharmacological and Biomolecular Sciences
University of Milan
Cardiology
University of Bern
Epidemiology and Preventive Pharmacology Service (SEFAP)
IRCCS Multimedica - Milano
Hospital de La Santa Creu I Sant Pau
Institut national de la santé et de la recherche médicale
Division of Endocrinology- Metabolism
Sorbonne Université
Public Health and Primary Care
Ghent University
Cardiology
Leiden University
University of Cambridge
Cardiology
Trinity College Dublin
Department of Cardiology
Charité – Universitätsmedizin Berlin
Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin
German Centre for Cardiovascular Research
Queen Mary University of London
Preventive Cardiology
University of Oslo
Clinical Medicine and Surgery
University of Naples Federico II
Cardiac Department
Athens Euroclinic
TIMI Study Group
Brigham and Women’s Hospital
Research Program for Clinical and Molecular Metabolism
University of Helsinki
Cardiology
Hacettepe University
Institute of Medicine
University of Gothenburg
Algerian Society of Cardiology
Armenian Cardiologists Association
Austrian Society of Cardiology
Azerbaijan Society of Cardiology
Latvian Society of Cardiology

Research output: Contribution to journal › Article › peer-review

997 Citations (Scopus)

Original language	English
Pages (from-to)	140-205
Number of pages	66
Journal	Atherosclerosis
Volume	290
DOIs	https://doi.org/10.1016/j.atherosclerosis.2019.08.014
Publication status	Published - Nov 2019
Externally published	Yes

Keywords

Apolipoprotein B
Cholesterol;
Dyslipidaemias
Familial hypercholesterolaemia
Guidelines
High-density lipoproteins
Lipoprotein remnants
Lipoprotein(a)
Low-density lipoproteins
Total cardiovascular risk
Treatment (adherence)
Treatment (drugs)
Treatment (lifestyle)
Triglycerides
Very low-density lipoproteins

Access to Document

10.1016/j.atherosclerosis.2019.08.014

Cite this

@article{18e9f71f1e7148ae81bf94c52156723f,

title = "2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk",

keywords = "Apolipoprotein B, Cholesterol;, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins",

author = "\{Authors/Task Force Members\} and \{ESC Committee for Practice Guidelines (CPG)\} and \{ESC National Cardiac Societies\} and Fran{\c c}ois Mach and Colin Baigent and Catapano, \{Alberico L.\} and Koskina, \{Konstantinos C.\} and Manuela Casula and Lina Badimon and Chapman, \{M. John\} and \{De Backer\}, \{Guy G.\} and Victoria Delgado and Ference, \{Brian A.\} and Graham, \{Ian M.\} and Alison Halliday and Ulf Landmesser and Borislava Mihaylova and Pedersen, \{Terje R.\} and Gabriele Riccardi and Richter, \{Dimitrios J.\} and Sabatine, \{Marc S.\} and Taskinen, \{Marja Riitta\} and Lale Tokgozoglu and Olov Wiklund and Stephan Windecker and Victor Aboyans and Collet, \{Jean Philippe\} and Veronica Dean and Donna Fitzsimons and Gale, \{Chris P.\} and Diederick Grobbee and Sigrun Halvorsen and Gerhard Hindricks and Bernard Iung and Peter J{\"u}ni and Katus, \{Hugo A.\} and Christophe Leclercq and Maddalena Lettino and Lewis, \{Basil S.\} and Bela Merkely and Christian Mueller and Steffen Petersen and Petronio, \{Anna Sonia\} and Marco Roffi and Evgeny Shlyakhto and Simpson, \{Iain A.\} and Miguel Sousa-Uva and Touyz, \{Rhian M.\} and Djamaleddine Nibouche and Zelveian, \{Parounak H.\} and Peter Siostrzonek and Ruslan Najafov and Gustavs Latkovskis",

year = "2019",

month = nov,

doi = "10.1016/j.atherosclerosis.2019.08.014",

language = "English",

volume = "290",

pages = "140--205",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - 2019 ESC/EAS guidelines for the management of dyslipidaemias

T2 - Lipid modification to reduce cardiovascular risk

AU - Authors/Task Force Members

AU - ESC Committee for Practice Guidelines (CPG)

AU - ESC National Cardiac Societies

AU - Mach, François

AU - Baigent, Colin

AU - Catapano, Alberico L.

AU - Koskina, Konstantinos C.

AU - Casula, Manuela

AU - Badimon, Lina

AU - Chapman, M. John

AU - De Backer, Guy G.

AU - Delgado, Victoria

AU - Ference, Brian A.

AU - Graham, Ian M.

AU - Halliday, Alison

AU - Landmesser, Ulf

AU - Mihaylova, Borislava

AU - Pedersen, Terje R.

AU - Riccardi, Gabriele

AU - Richter, Dimitrios J.

AU - Sabatine, Marc S.

AU - Taskinen, Marja Riitta

AU - Tokgozoglu, Lale

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Aboyans, Victor

AU - Collet, Jean Philippe

AU - Dean, Veronica

AU - Fitzsimons, Donna

AU - Gale, Chris P.

AU - Grobbee, Diederick

AU - Halvorsen, Sigrun

AU - Hindricks, Gerhard

AU - Iung, Bernard

AU - Jüni, Peter

AU - Katus, Hugo A.

AU - Leclercq, Christophe

AU - Lettino, Maddalena

AU - Lewis, Basil S.

AU - Merkely, Bela

AU - Mueller, Christian

AU - Petersen, Steffen

AU - Petronio, Anna Sonia

AU - Roffi, Marco

AU - Shlyakhto, Evgeny

AU - Simpson, Iain A.

AU - Sousa-Uva, Miguel

AU - Touyz, Rhian M.

AU - Nibouche, Djamaleddine

AU - Zelveian, Parounak H.

AU - Siostrzonek, Peter

AU - Najafov, Ruslan

AU - Latkovskis, Gustavs

PY - 2019/11

Y1 - 2019/11

KW - Apolipoprotein B

KW - Cholesterol;

KW - Dyslipidaemias

KW - Familial hypercholesterolaemia

KW - Guidelines

KW - High-density lipoproteins

KW - Lipoprotein remnants

KW - Lipoprotein(a)

KW - Low-density lipoproteins

KW - Total cardiovascular risk

KW - Treatment (adherence)

KW - Treatment (drugs)

KW - Treatment (lifestyle)

KW - Triglycerides

KW - Very low-density lipoproteins

UR - https://www.scopus.com/pages/publications/85072794956

U2 - 10.1016/j.atherosclerosis.2019.08.014

DO - 10.1016/j.atherosclerosis.2019.08.014

M3 - Article

C2 - 31504418

AN - SCOPUS:85072794956

SN - 0021-9150

VL - 290

SP - 140

EP - 205

JO - Atherosclerosis

JF - Atherosclerosis

ER -

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Keywords

Access to Document

Other files and links

Cite this